Jason D Walker
Overview
Explore the profile of Jason D Walker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
506
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horwood C, Patel N, Walker J, Evans C
J Cardiothorac Vasc Anesth
. 2024 Jun;
38(9):1899-1906.
PMID: 38942683
Objectives: Anemia and iron deficiency in patients having cardiac surgery increases their perioperative risk. Nonanemic iron deficiency (NAID) in this group is less well-described. We aimed to investigate the incidence...
2.
Gokhale A, Sable R, Walker J, McLaughlin L, Kousoulas K, Jois S
Biopolymers
. 2015 Jun;
104(6):733-42.
PMID: 26031942
CD2 and CD58 are two important costimulatory molecules involved in generating the signal II required for normal immune signaling. However, this interaction can be targeted to be of benefit in...
3.
Stanfield B, Stahl J, Chouljenko V, Subramanian R, Charles A, Saied A, et al.
PLoS One
. 2014 Oct;
9(10):e109890.
PMID: 25350288
Herpes Simplex Virus type-1 (HSV-1) and type-2 (HSV-2) establish life-long infections and cause significant orofacial and genital infections in humans. HSV-1 is the leading cause of infectious blindness in the...
4.
Iyer A, Pahar B, Chouljenko V, Walker J, Stanfield B, Kousoulas K
Virol J
. 2013 Oct;
10:317.
PMID: 24165088
Background: Herpes simplex virus type-1(HSV-1) and HSV-2 are important human pathogens that cause significant ocular and urogenital complications, respectively. We have previously shown that HSV-1 virions lacking glycoprotein K (gK)...
5.
Kim I, Chouljenko V, Walker J, Kousoulas K
J Virol
. 2013 May;
87(14):8029-37.
PMID: 23678175
Herpes simplex virus 1 (HSV-1) facilitates virus entry into cells and cell-to-cell spread by mediating fusion of the viral envelope with cellular membranes and fusion of adjacent cellular membranes. Although...
6.
Chowdhury S, Naderi M, Chouljenko V, Walker J, Kousoulas K
Virol J
. 2012 Jun;
9:112.
PMID: 22695228
Background: Herpes simplex virus type-1 (HSV-1) enters into cells via membrane fusion of the viral envelope with plasma or endosomal membranes mediated by viral glycoproteins. HSV-1 virions attach to cell...
7.
Chouljenko D, Kim I, Chouljenko V, Subramanian R, Walker J, Kousoulas K
J Virol
. 2012 Feb;
86(8):4262-70.
PMID: 22318149
Herpes simplex virus 1 (HSV-1) viral glycoproteins gD (carboxyl terminus), gE, gK, and gM, the membrane protein UL20, and membrane-associated protein UL11 play important roles in cytoplasmic virion envelopment and...
8.
Jambunathan N, Chowdhury S, Subramanian R, Chouljenko V, Walker J, Kousoulas K
J Virol
. 2011 Oct;
85(24):12910-8.
PMID: 21994443
Herpes simplex virus 1 (HSV-1) glycoprotein K (gK) is expressed on virions and functions in entry, inasmuch as HSV-1(KOS) virions devoid of gK enter cells substantially slower than is the...
9.
Kasili R, Huang C, Walker J, Simmons L, Zhou J, Faulk C, et al.
Development
. 2011 May;
138(11):2379-88.
PMID: 21558384
Endoreplication, also called endoreduplication, is a modified cell cycle in which DNA is repeatedly replicated without subsequent cell division. Endoreplication is often associated with increased cell size and specialized cell...
10.
Walker J, Sehgal I, Kousoulas K
J Virol
. 2011 May;
85(14):7363-71.
PMID: 21543507
Oncolytic herpes simplex virus 1 (HSV-1) viruses armed with immunomodulatory transgenes have shown potential for enhanced antitumor therapy by overcoming tumor-based immune suppression and promoting antitumor effector cell development. Previously,...